Patents Assigned to Roche Medical Systems, Inc.
  • Patent number: 11971333
    Abstract: A system, an instrument, a computer-implemented method, and a clinical workflow for mesodissection of biological specimens on tissue slides by incorporating annotations. An image of an annotated reference slide is acquired and transposed onto a plurality of serial samples on the tissue slides along with the corresponding annotations and metadata. The serial samples are milled based on the annotations, and the milled tissue is automatically collected along with a milling buffer solution inside milling tips, and then dispensed in designated collection vials. The instrument automates the filling of aqueous buffer inside the milling tips and the monitoring of the buffer solution and the sequential filling of the milling tips. The workflow provides an integrated interface that performs tissue annotation, alignment, dissection, tracking, and reporting on a single screen. The degree of precision, ease of use and repeatability will improve PCR and NGS test results, ultimately providing timely patient results.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: April 30, 2024
    Assignees: Ventana Medical Systems, Inc., Roche Sequencing Solutions, Inc.
    Inventors: Nils B. Adey, Dale B. Emery, Leonid Fomin, Rene M. Guerrero, Emmanuel Naouri, Robert J. Parry, Peter Romanowich
  • Patent number: 8722379
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: May 13, 2014
    Assignee: Roche Medical Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers